IBMS Congress 2025

Chantell Hodgson

Scheme Manager , LabXCell CEO and UK NEQAS Cellular Pathology Technique (CPT) Scheme Director UK NEQAS for CPT

For the past 10 years Chantell has been the Scheme Manager for UK NEQAS CPT, leading a “not for profit” organisation which provides a comprehensive range of EQA and proficiency testing programmes for all aspects of tissue diagnostics. She has almost 30 years’ experience in cellular pathology and immunocytochemistry, both in a research and diagnostic setting Lead for UK NEQAS CPT educational provision to support in house training and development of Biomedical Scientists and supporting staff. 

Chantell is also the UK NEQAS Vice-President for Communications, Deputy Chair of the IBMS Cellular Pathology Advisory Committee, Guest Lecturer at a number of Universities for Biomedical Science Speaker at international meetings and conferences, as well as IBMS Registration and Specialist Portfolio Assessor Contributor to the Oxford University Press (OUP) Histopathology textbook series.

---

Paul Scorer

UK NEQAS Cellular Pathology Technique (CPT)

Paul became a freelance educator/lecturer in 2023 and is currently an Educational Co-ordinator/Assessor for UK NEQAS CPT. Since 2016 he has been involved in delivering UK NEQAS CPT educational presentations/workshops on histological technique, specialist staining and immunohistochemistry.

Paul has over 40 years’ experience in clinical histology/IHC, companion diagnostic (CDx) assay testing, pharmaceutical development, project leading and quality control. Paul began his career in histopathology at the Queen Elizabeth Hospital, Gateshead, where he spent 25 years, including 18 years as senior BMS leading IHC services. Paul moved into private industry, joining Vision Biosystems, Newcastle, (subsequently Leica Biosystems) spending 12 years in QC, R&D and CDx assay development. In 2015 Paul joined AstraZeneca, Cambridge, as Associate Principal Scientist spending 6 years in Precision Medicine focused on the development of immunotherapies and IHC CDx assays targeting PD-L1 expressing tumours.

In 2021 Paul joined Oncologica UK Ltd, Cambridge, a clinical laboratory providing personalised, genetic sequencing and therapy guidance to cancer patients. As Principal Scientist in Histology, he was responsible for all histological/IHC testing and the co-ordination of research into new therapy linked diagnostic genetic testing.

Paul has also co-authored 14 peer reviewed, IHC related, scientific publications.

---

Cassandra Cooklynn

Dissection Practitioner , Mersey and West Lancashire Teaching Hospitals NHS Trust

Cassandra has worked in a histology department for several years with over 6 years as a Dissection Practitioner. She completed an Applied Biomedical Sciences course at John Moores University and began working at St Helens & Knowsley Teaching Hospitals NHS Trust as a Biomedical Scientist. She completed the STP qualification in 2017 followed by the IBMS Diploma of Expert Practice and Advanced Specialist Diploma in Breast Pathology. She has done supplementary courses in teaching and training which has been useful in training fellow Biomedical Scientists in dissection practice. She is also currently enjoying being on the Cellular Pathology Advisory Panel for the IBMS.

---

Jack Tang

University Hospitals of Leicester NHS Trust

No bio provided

---

Jack Tang

University Hospitals of Leicester NHS Trust

No bio provided

---

Dr Guy Orchard

Consultant Biomedical Scientist, Synnovis Analytics, London

Guy is responsible for providing and developing the dermatopathology, Mohs’ micrographic surgery and trichogram diagnostic services for the Unit. Guy is actively involved in teaching and training both within the Guy’s and St. Thomas’ Trust framework but also as an external lecturer at several Universities throughout the country for students studying  for MSc’s  in biomedical science.

Guy completed his Fellowship to the IBMS in Cellular Pathology in 1990 having gained the highest pass in the UK across all disciplines and being awarded the RJ Lavington Prize. Guy completed his Master’s in immunology at Surrey University gaining a distinction in 1995 and achieved he’s PhD in 2010. He has worked at St. John’s for nearly his entire working career, which now spans over 35 years service.

Guy received chartered scientist recognition in 2005. He has won two international awards from the National Society of Histotechnologists (NSH), the first in 2015 The Leica Leadership Award for Teaching and Education and another in 2019 The Leica Leadership Award in Management and Training. In addition, Guy is the Advancing Health Care awards winner of the IBMS sponsored Biomedical Scientist of the Year 2020.

Guy has been responsible for expanding and developing the dermatopathology and Mohs’ laboratory services. The Mohs services within St. John’s, is now the largest within the UK and Guy has a keen interest in the development of Mohs techniques not only within St. John’s but also throughout the UK.  He has been involved in research and development activities for the department in several areas of pathology involving immunocytochemistry techniques. 

Guy has recently been involved in expanding and fully automating the immunocytochemistry service and has encompassed double-labelling and in-situ procedures for the department as new protocols. He has an active interest in lymphoma and melanoma research and participates in assisting researchers or publishing his own contributions in the field.

Guy is professionally active and is the deputy editor of The British Journal of Biomedical Sciences and sits on four other editorial boards as well as peer reviewing for several other journals. He is an immunocytochemistry UK National external quality assurance (UKNEQAS) assessor, lecturer and short course coordinator.  He is also a UKNEQAS Cellular Pathology Technique (CPT) lead assessor for Mohs. He has previously held a council position for the IBMS and is now the IBMS Chief Examiner for the cellular pathology specialist panel. Guy sits on the advanced Specialist examination con-joint boards for the IBMS and Royal College of Pathologists for histodissection, immunocytochemistry and Biomedical Scientists reporting.

Guy is the appointed Lead for the British Society of Mohs Histologists and chairman for the newly formed advanced specialist examination board for the IBMS in Mohs. Guy has also been a Director for the American Society of Mohs Histotechnologists (ASMH). He regularly teaches on the MSc dermatology course for King’s Medical School London and Westminster University. Guy has edited and contributed to Oxford University Press (OUP) ‘Histopathology’ text book for  the Fundamentals in Biomedical Science series and has just completed  a second book ‘ Cellular Structure and Function’  and is now working on a third book in the same series for OUP entitled Cellular Pathology. He has also contributed a chapter on ‘Pigments’ to Survana and Layton’s ‘Bancrofts Theory and Practice of Histological Techniques’ seventh and eighth editions.

---

Fitim Berisha

UK NEQAS ICC & ISH

Fitim is a Senior Staff Scientist at UK NEQAS for ICC & ISH. Early in his career, he gained HCPC Registration as a Biomedical Scientist, and has over 20 years’ experience in the field of Cellular Pathology. Fitim has considerable experience within routine histology, immunohistochemistry and molecular pathology, with a particular interest in sarcoma. And over the past years he has contributed to a number of research projects in this area.

As part of his role as Staff Scientist at UK NEQAS ICC & ISH, Fitim participates in several of the general and specialised assessment modules, and provides technical support to participants.

---

Andrew Dodson MPhil, FIBMS, CSci

Scheme Director, UK NEQAS Immunocytochemistry & In-Situ Hybridisation (ICC & ISH)

Andrew began his career in 1981, as a trainee biomedical scientist in the Histopathology Department at St. George's Hospital in London and qualified as a Fellow of the Institute of Biomedical Science in 1986. Subsequently he worked as a research scientist with the British Heart Foundation, also at St. George’s. In 1990 Andrew moved to Liverpool and took up a post within the immunocytochemistry (ICC) laboratories at the Royal Liverpool University Hospital, where he ran the Immunocytochemistry and latterly, the Molecular Pathology laboratories.

In 2014 he returned to London to work in the Breast Cancer Research Centre at the Royal Marsden Hospital as its senior clinical research scientist. In 2018 Andrew  was appointed as the Director of UK NEQAS for Immunocytochemistry and In-Situ Hybridisation.

---

Dr Tony O'Grady

Chief Medical Scientist, Royal College of Surgeons in Ireland (RSCI), Education & Research Centre

Tony O'Grady is the Chief Medical Scientist in the Department of Pathology at the Royal College of Surgeons in Ireland. He works in a Molecular Pathology laboratory providing an ISO15189-accredited clinical service to Hospitals throughout Ireland. The laboratory performs analysis on solid tumour samples using Next Generation Sequencing (NGS), Immunocytochemistry (IHC), Fluorescence in Situ Hybridization (FISH) and quantitative PCR. His research interests include the metastatic potential of non-melanoma skin cancer in the organ transplant population and he is co-author of over 100 papers in peer-reviewed journals.

Tony has acted as an assessor for UK NEQAS for the past 16 years.

---

David Allen

Health Services Laboratories, London

David Allen is a Biomedical Scientist and Cellular Pathology Manager at Health Services Laboratories (HSL). After studying Biomedical Science in Dublin, he worked in clinical and research laboratories in Ireland, joined University College London (UCL) in 2013 as a Senior Biomedical Scientist and then Head of UCL-Advanced Diagnostics in 2015. The service successfully transitioned to HSL in 2018.

His current role oversees activities of the core HSL Cellular Pathology services; Histology, Diagnostic Cytology and HSL-Advanced Diagnostics.

---

Dr Ashirward Merve

Great Ormond Street Hospital for Children NHS Foundation Trust and University College London Hospitals NHS Foundation Trust

I am a Consultant Neuropathologist based in London. I work across two sites - Great Ormond Street Hospital for Children (GOSH) and National Hospital for Neurology and Neurosurgery (Queen Square), with my work involving diagnostics in both adult and paediatric settings. Majority of our workload includes tumours. But I also undertake assessment of muscle biopsy, epilepsy, neurodegeneration, and neuroinflammatory pathology. I am familiar with UK NEQAS as I regularly participate as an assessor for immunohistochemistry, Neuro module. I participate in research and teaching activities and hold an Honorary Contract with University College London (UCL).

: ashirwad-merve-716253b3

---

Sian Wood

The Royal Marsden NHS Foundation Trust

Sian Wood is the lead Clinical Scientist on the Marsden360 ctDNA service at the Royal Marsden Hospital. As part of the North Thames Genomic Medicine Service, the Marsden360 service is provided for patients with suspected late-stage lung cancer, as part of the NHS England study in ctDNA testing in non small cell lung cancer.  

Sian was previously a Clinical Scientist in the Solid Tumour team at the All Wales Medical Genomics Service where she also undertook my training towards HCPC registration. Prior to embarking on a career as a Clinical Scientist, Sian worked in the research setting and studied for her PhD at Swansea University.

---

Lorren Mitchell

UK NEQAS Cellular Pathology Technique (CPT)

Lorren Mitchell is the Scheme Manager for UK NEQAS Cellular Pathology Technique. She is responsible for the day-to-day operations and long-term strategic management of the service. Her role  focuses on ensuring operational efficiency, driving performance excellence, and fostering commercial growth. Lorren oversees the development and delivery of services, aligning them with key performance indicators to achieve the highest standards of operational and commercial success.

Lorren has over 15 years of experience in Cellular Pathology within a diagnostic setting with extensive involvement in the implementation of Digital Pathology. A HCPC registered Biomedical Scientist, member of the IBMS, IBMS verifier and examiner.

---

Paul Scorer

UK NEQAS Cellular Pathology Technique (CPT)

Paul became a freelance educator/lecturer in 2023 and is currently an Educational Co-ordinator/Assessor for UK NEQAS CPT. Since 2016 he has been involved in delivering UK NEQAS CPT educational presentations/workshops on histological technique, specialist staining and immunohistochemistry.

Paul has over 40 years’ experience in clinical histology/IHC, companion diagnostic (CDx) assay testing, pharmaceutical development, project leading and quality control. Paul began his career in histopathology at the Queen Elizabeth Hospital, Gateshead, where he spent 25 years, including 18 years as senior BMS leading IHC services. Paul moved into private industry, joining Vision Biosystems, Newcastle, (subsequently Leica Biosystems) spending 12 years in QC, R&D and CDx assay development. In 2015 Paul joined AstraZeneca, Cambridge, as Associate Principal Scientist spending 6 years in Precision Medicine focused on the development of immunotherapies and IHC CDx assays targeting PD-L1 expressing tumours.

In 2021 Paul joined Oncologica UK Ltd, Cambridge, a clinical laboratory providing personalised, genetic sequencing and therapy guidance to cancer patients. As Principal Scientist in Histology, he was responsible for all histological/IHC testing and the co-ordination of research into new therapy linked diagnostic genetic testing.

Paul has also co-authored 14 peer reviewed, IHC related, scientific publications.

---

Dawn Wilkinson

Deputy Scheme Manager , UK NEQAS Immunocytochemistry & In-Situ Hybridisation (ICC & ISH)

Dawn Wilkinson is currently the Deputy Scheme Manager for UK NEQAS ICC and ISH. She has been a full-time member of staff and a lead assessor at UK NEQAS ICC and ISH for over 4 years and has been an external assessor for UK NEQAS over the years while working in the NHS. Dawn has worked as a Biomedical Scientist in several large teaching hospitals across London.

As a Senior Scientific Officer and Core Facility Manager at Breast Cancer Research at the ICR, Operations Manager within private laboratory healthcare and as a Scientific Director within the pharmaceutical industry. She has 35 years’ experience in the Cellular Pathology field and has been a Fellow of the IBMS for over 25 years. While working in Industry she was part of a team who worked on precision medicines being brought to market.

---

Suzanne Parry

Scheme Manager , UK NEQAS ICC & ISH

Suzanne is the Scheme Manager for the UK NEQAS Immunocytochemistry and In Situ Hybridisation Scheme. Her principal role is to oversee all operational aspects of the large international organisation, monitoring quality within the setting of clinical healthcare services. She started her career as a Biomedical Scientist in Cellular Pathology after graduating with a Biomedical Sciences degree. Suzanne went on to complete her professional training in histology and cellular pathology, and successfully obtained state registration to join the HCPC, her MSc in Biomedical Sciences, and Fellow membership within the IBMS.

Suzanne’s previous work appointments have primarily been within the field of cellular pathology, in both the clinical diagnostic and research fields, with an interest in breast pathology and research. And over the years she has contributed to and co-authored a number of papers in peer-reviewed journals. Suzanne has a keen interest in education and is a module tutor on the MSc Biomed Online Course at the University of Greenwich. She also sits on the Institute of Biomedical Science Cellular Pathology Advisory Panel.

---

Mohammad Shams

Senior Biomedical Scientist, Synnovis Analytics, London

Mohammed (Behzad) is Senior Biomedical scientist providing services for the dermatopathology laboratory, Such as: Mohs’ micrographic surgery, Immunohistochemistry, Paraffin processing. Behzad has a long-term experience on Mohs micrographic surgery in most of the Mohs centre across the England. He provides several training course and lecturing for Mohs surgery across the world as well as lecturing at the American Mohs Society of Histology (ASMH) conference.

Behzad completed his Master’s in biomedical science at London University of Surrey. He is working at St Thomas’s Hospital, St. John’s Institute of Dermatology, which is one of the busiest and largest Mohs centre in the United Kingdom. During his career at Oxford University Hospital he develops and setup the new technique for Mohs micrographic procedure.

Behzad is a member & lecturer of: American Mohs Society (ASMH), National Society for Histology ( NSH) ,  Institute of Biomedical science (IBMS)  

---

Paul Chenery

Cellular Pathology Service Manager & Deputy Pathology Directorate, Nottingham University Hospitals NHS Trust

Paul Chenery is currently the Cellular Pathology Service Manager & Deputy Pathology Directorate Manager at Nottingham University Hospitals NHS Trust (NUH). His training has been focused in Histopathology, starting his career 13 years ago working as a Medical Laboratory Assistant at Sheffield Teaching Hospitals straight from university.

Paul developed, progressed and advanced to the Molecular Lead role at Sheffield before taking up the Quality & Training Manager role at NUH. He was then promoted to his current position as a Senior Manager and is responsible for leading one of the biggest and most successful transformational changes within the department earning recognition nationally.

Paul values inclusivity in the workplace and has a passion to guide and mentor. He has aspirations to progress through senior management to divisional/executive levels being able to influence a broader scope of practice, helping departments to embrace change, developing a continual improvement culture.

---

Scott Gable

Laboratory and Mortuary Service Manager, Cardiff and Vale University Health Board

I am a Biomedical Scientist with over 30 years of cellular pathology experience across NHS England and NHS Wales, in district general hospitals and tertiary teaching hospitals. I am a Fellow of the institute and currently Cellular Pathology scientific service lead at the University Hospital of Wales.

I have had the privilege on supporting the development of cell path laboratories in both Ethiopia and Sierra Leone. I have been an EQA assessor almost as long as I have practiced, recognising the critical value of participation. I also have the pleasure of assessing laboratories for UKAS against the 15189 standards.

---

Anna Ikin

Formerly of Liverpool University Hospitals NHS Foundation Trust

Anna is a highly experienced biomedical scientist with over 27 years of dedicated NHS service specialising in cellular pathology. Throughout her career, Anna has witnessed the evolving landscape of healthcare through advancements, setbacks, and the unprecedented demands of a pandemic. Her commitment has remained steadfast in a healthcare environment that is anything but predictable. With a wealth of experience, Anna has faced and adapted to these changes, always upholding her dedication to patient care, even in the most demanding circumstances.

Her passion for health extends beyond the laboratory. With further study and experience in nutrition and dietetics and nutritional therapy, Anna brings an understanding that effective healthcare rests not only on rigorous science but also on supporting the humanity of those who deliver it - a perspective earned through decades of both technical achievement, further study and navigating the complexities of challenging work environments.

---

Rob Hughes

Northern Lincolnshire and Goole NHS Foundation Trust

I have worked as a Biomedical Scientist in Cellular Pathology for over 35 years, in both teaching hospital and general hospital settings. Over the last 18 years I have held laboratory management positions with Path Links Pathology in Lincolnshire. Path Links is an NHS service and delivers Pathology for the whole of Greater Lincolnshire, formed in the late 1990’s was one of the first networked pathology services in the UK.

For the last five years I have held the role of Directorate Manager with the responsibility for writing business cases for service development and delivery of the associated projects.

---

Vicky Willis

Lecturer, Nottingham Trent University

Vicky studied Biomedical Science at De Montfort University in Leicester and graduated with a first-class honours' degree in 2001 and was awarded the IBMS Presidents Prize. She did her placement year in Cellular Pathology at the University Hospitals of Leicester and stayed there for the whole of her 25-year career. She became the departments Training Officer in 2018 supporting numerous students through their IBMS Certificate of Competence and providing training sessions for all of the trainee staff in Pathology at Leicester.

In 2024 she followed her passion for training by taking a lecturing role at Nottingham Trent University where she lectures on the Biomedical Science degrees and has established an IBMS Portfolio Club to support the students. Vicky has been an active IBMS verifier and specialist portfolio examiner for a number of years which she will continue in her new role.

---

Dr Muhammad Aslam MBBS, FRCPATH, MBA (Health care)

Consultant Pathologist, National Clinical Lead for Wales to support digital pathology and AI implementation projects, Betsi Cadwaladr University Health Board

No bio provided

---

Dr Catriona Dunn

Postdoctoral Researcher, National Pathology Imaging Cooperative

No bio provided

---

Professor David Brettle

Trust Chief Scientific Officer, National Pathology Imaging Cooperative

David is the Chief Scientific Officer at Leeds Teaching Hospitals NHS Trust and has an honorary chair in healthcare science from the University of Salford.

Prior to becoming the Trust CSO he was the Head of Medical Physics and Engineering at Leeds for 11 years and prior to that worked at the Christie hospital.  Whilst Head of Medical Physics at Leeds he completed a term  as President of the institute of Physics in Engineering and Medicine. 

His current role has many elements including professional lead for the 1230 Healthcare Scientists in Leeds, research into the impact of image quality in digital pathology at the National Pathology Imaging Co-operative and  leading on innovation and technology for the two new hospitals being built in Leeds.  In this last role he set up the ‘award winning’ Innovation Pop-up at Leeds which aims to stimulate the culture of innovation in the hospital and allow new technologies to be developed and evaluated through partnership and collaboration with academic partners and industry.

---

James Howe

Specialist Biomedical Scientist - Digital Pathology, Royal Derby Hospital

James Howe is a Digital Clinical Change Lead and Specialist Biomedical Scientist at University Hospitals of Derby and Burton NHS Foundation Trust. He specialises in the integration of digital systems into clinical environments, with particular expertise in Digital Pathology. His work has included the roll-out of a new Laboratory Information Management System (LIMS) and Specimen Tracking Solutions, as well as contributions to the implementation of a cross-Trust Electronic Patient Record (EPR) system. is a Digital Clinical Change Lead and Specialist Biomedical Scientist at University Hospitals of Derby and Burton NHS Foundation Trust. He specialises in the integration of digital systems into clinical environments, with particular expertise in Digital Pathology. His work has included the roll-out of a new Laboratory Information Management System (LIMS) and Specimen Tracking Solutions, as well as contributions to the implementation of a cross-Trust Electronic Patient Record (EPR) system.

In addition, James has been involved in the validation and integration of CE-IVD approved deep-learning image analysis algorithms to assist in quantifying ER, PR, and HER2 scoring in breast core biopsies.

Building on his work with the Topol Digital Fellowship, James is currently researching device-independent colour calibration. This includes studying the range of deviations among commercially available scanners, understanding their impact, and developing methods to standardise and correct for these differences.

---

Laura Holland

Assessment Manager – Healthcare, UKAS

No bio provided

---

Chris Ward

Head of Examinations, Institute of Biomedical Science

Chris is the Head of Examinations at the Institute of Biomedical Science (IBMS) which he joined in January 2014. At the IBMS he has responsibility for the Certificate of Expert (CEP) distance learning qualifications, and all the DEP, ASD and HSD qualifications that the Institute offers including those in Dissection, Reporting and Cytology. He co-ordinates the work of eight specialist advisory panels, three RCPath/IBMS Conjoint Boards and the UKTLC and is also involved in the (re)accreditation of IBMS accredited BSc and MSc degree programmes.

Before working at the IBMS he had spent four and half years at another professional body and eight and half years at the qualifications regulator for England called at the time the Qualifications and Curriculum Authority (QCA).

---

Peter Smith

Consultant Clinical Scientist, Liverpool University Hospitals NHS Foundation Trust

Peter is a Consultant Clinical Scientist in Gynae Histopathology, having completed the IBMS/RCPath Advanced Specialist Diploma in Histopathology Reporting in 2024.

He has  worked in histopathology for 12 years as both a Biomedical and Clinical Scientist, with the majority of his pre-reporting experience lying in specimen dissection, digital pathology and molecular oncology.

Peter is currently the joint Lead Assessor and Lead Assessment Content Editor for the Histopathology STP, and work as the Cervical Screening Provider Lead for Royal Liverpool University Hospital.

---

Rasiyan Salih

Biomedical Scientist, Synnovis Analytics

No bio provided

---

Dr Guy Orchard

Consultant Biomedical Scientist, Synnovis Analytics, London

Guy is responsible for providing and developing the dermatopathology, Mohs’ micrographic surgery and trichogram diagnostic services for the Unit. Guy is actively involved in teaching and training both within the Guy’s and St. Thomas’ Trust framework but also as an external lecturer at several Universities throughout the country for students studying  for MSc’s  in biomedical science.

Guy completed his Fellowship to the IBMS in Cellular Pathology in 1990 having gained the highest pass in the UK across all disciplines and being awarded the RJ Lavington Prize. Guy completed his Master’s in immunology at Surrey University gaining a distinction in 1995 and achieved he’s PhD in 2010. He has worked at St. John’s for nearly his entire working career, which now spans over 35 years service.

Guy received chartered scientist recognition in 2005. He has won two international awards from the National Society of Histotechnologists (NSH), the first in 2015 The Leica Leadership Award for Teaching and Education and another in 2019 The Leica Leadership Award in Management and Training. In addition, Guy is the Advancing Health Care awards winner of the IBMS sponsored Biomedical Scientist of the Year 2020.

Guy has been responsible for expanding and developing the dermatopathology and Mohs’ laboratory services. The Mohs services within St. John’s, is now the largest within the UK and Guy has a keen interest in the development of Mohs techniques not only within St. John’s but also throughout the UK.  He has been involved in research and development activities for the department in several areas of pathology involving immunocytochemistry techniques. 

Guy has recently been involved in expanding and fully automating the immunocytochemistry service and has encompassed double-labelling and in-situ procedures for the department as new protocols. He has an active interest in lymphoma and melanoma research and participates in assisting researchers or publishing his own contributions in the field.

Guy is professionally active and is the deputy editor of The British Journal of Biomedical Sciences and sits on four other editorial boards as well as peer reviewing for several other journals. He is an immunocytochemistry UK National external quality assurance (UKNEQAS) assessor, lecturer and short course coordinator.  He is also a UKNEQAS Cellular Pathology Technique (CPT) lead assessor for Mohs. He has previously held a council position for the IBMS and is now the IBMS Chief Examiner for the cellular pathology specialist panel. Guy sits on the advanced Specialist examination con-joint boards for the IBMS and Royal College of Pathologists for histodissection, immunocytochemistry and Biomedical Scientists reporting.

Guy is the appointed Lead for the British Society of Mohs Histologists and chairman for the newly formed advanced specialist examination board for the IBMS in Mohs. Guy has also been a Director for the American Society of Mohs Histotechnologists (ASMH). He regularly teaches on the MSc dermatology course for King’s Medical School London and Westminster University. Guy has edited and contributed to Oxford University Press (OUP) ‘Histopathology’ text book for  the Fundamentals in Biomedical Science series and has just completed  a second book ‘ Cellular Structure and Function’  and is now working on a third book in the same series for OUP entitled Cellular Pathology. He has also contributed a chapter on ‘Pigments’ to Survana and Layton’s ‘Bancrofts Theory and Practice of Histological Techniques’ seventh and eighth editions.

---